PER Events, LLC, an affiliate of accredited medical education provider Physicians’ Education ResourceÂ®
), today announced its acquisition of the renowned multitumor cancer conference, the Chemotherapy Foundation Symposium Innovative Cancer Therapy for TomorrowÂ®
This acquisition combines the legacy of one of the largest oncology/hematology conferences with PER’s expanding portfolio of educational meetings to keep oncologists and their practices up-to-date on the latest advances in cancer treatment.Â Additionally, it deepens the commitment of Michael J. Hennessy Associates, Inc. (MJH), corporate parent of PER and OncLiveÂ®
, to advancing cancer care through a broad range of educational, research, and communications services for the oncology community.
“We are excited to add the Chemotherapy Foundation Symposium to the rich offerings in our continuing education portfolio at Physicians’ Education Resource and to our broader oncology-focused enterprises serving cancer patients, cancer centers, advocacy groups, healthcare providers and caregivers all over the world,” said MJH Chairman and CEO Michael J. Hennessy, Sr.
Every year the Chemotherapy Foundation Symposium, the premier gathering of oncologists in the Northeast, updates approximately 2,000 oncologists, oncology nurses, pharmacists and other healthcare professionals on the latest developments across a wide range of therapeutic categories and tumor types. This year’s symposium, to be held November 4 to 6 in New York City, will retain its educational focus on new developments in cancer therapeutics. The symposium will also provide oncology professionals with the opportunity to learn about new compounds, novel approaches to diagnosis and treatment with currently available agents, ongoing clinical trials and emerging developments that define current progress aimed at the goal of control and cure of cancer.
“The addition of this historic symposium enhances PER’s ability to deliver on our commitment to advancing cancer care through professional education,” said Phil Talamo, vice president, independent medical education and operations at PER. “With the Chemotherapy Foundation Symposium’s focus on ‘Innovative Cancer Therapy for Tomorrow,’ this well-attended conference will improve outcomes for thousands of cancer patients each year by educating oncologists on state-of-the-art care.”
PER provides high-quality live and online education featuring leading national and international faculty. Continuing education activities from PER enable healthcare providers to bring breakthroughs to their practices and their patients quickly by educating them on advances and updates to standards of care in both treatment and disease management.
“Widening the Chemotherapy Foundation’s information network through PER’s national and international oncology meetings will give additional impetus to our already established international presence,” said conference co-chair Franco Muggia, MD. “We look forward to PER building on the exceptional legacy of Jaclyn Silverman, our conference management director since the Chemotherapy Foundation Symposium’s inception.”
The conference’s other co-chair, Edward Ambinder, MD, agrees. “Since 1972, the Chemotherapy Foundation Symposium, which was founded by Dr. Ezra Greenspan and presented in association with the Icahn School of Medicine at Mount Sinai and the Tisch Cancer Institute, has been educating all types of academic, community and international oncologists about the latest information on cancer care, including therapies, information technology and governmental regulation. With PER taking ownership of the Chemotherapy Foundation Symposium beginning this year, we will all benefit from its medical meeting management skills, novel educational tools, time-tested formats and excellent medical speakers.”
The Chemotherapy Foundation Symposium is just the most recent addition to MJH’s portfolio in the cancer field. MJH continues to expand its Strategic Alliance Partnership (SAP) program, which teams the acclaimed OncLive
) platform of resources for the practicing oncologist with 44 leading cancer centers, most of which are recognized by the National Cancer Institute, nursing schools and physician groups. OncLive
’s offerings include the renowned Peer Exchange and OncLive Insights video series; OncLive News Network, which provides the latest in breaking news on a 24/7 basis, and a full suite of monthly and quarterly publications which includes OncologyLive, Oncology & Biotech News, Oncology Nursing News, Urologists in Cancer Care, Oncology Business Management
and Contemporary Oncology
is also the official communications partner of PER.